Dosing and Safety of Once-Weekly Rifapentine and Isoniazid for 12 Weeks for Tuberculosis Preventive Therapy in Children With and Without HIV: Protocol for a Phase I/II Open-Label, Exposure-Controlled, Dose-Finding, and Safety Study (Tuberculosis Trials Consortium Study 35)

Ingrid Courtney, Meredith G Dixon, Louvina van der Laan, Rada Savic, Belen Solans, Kelly Dooley, Deron Burton, Shaun Barnabas, Avy Violari, Kia Bryant, Nigel Scott, Patrick Phillips, Erin Sizemore, Wendy Carr, Susan Purchase, Elri Nortier, Joh-Nell van der Westhuizen, Anne-Marie Demers, Anneke Hesseling, Rosanna Boyd

Open source

DOI: 10.2196/103274
Published: 2026-09-30
Container: JMIR Research Protocols
Publisher: JMIR Publications Inc.
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.2196/103274,
  title = {Dosing and Safety of Once-Weekly Rifapentine and Isoniazid for 12 Weeks for Tuberculosis Preventive Therapy in Children With and Without HIV: Protocol for a Phase I/II Open-Label, Exposure-Controlled, Dose-Finding, and Safety Study (Tuberculosis Trials Consortium Study 35)},
  author = {Ingrid Courtney and Meredith G Dixon and Louvina van der Laan and Rada Savic and Belen Solans and Kelly Dooley and Deron Burton and Shaun Barnabas and Avy Violari and Kia Bryant and Nigel Scott and Patrick Phillips and Erin Sizemore and Wendy Carr and Susan Purchase and Elri Nortier and Joh-Nell van der Westhuizen and Anne-Marie Demers and Anneke Hesseling and Rosanna Boyd},
  year = {2026},
  journal = {JMIR Research Protocols},
  doi = {10.2196/103274},
  url = {https://doi.org/10.2196/103274}
}

RIS

TY  - JOUR
TI  - Dosing and Safety of Once-Weekly Rifapentine and Isoniazid for 12 Weeks for Tuberculosis Preventive Therapy in Children With and Without HIV: Protocol for a Phase I/II Open-Label, Exposure-Controlled, Dose-Finding, and Safety Study (Tuberculosis Trials Consortium Study 35)
AU  - Ingrid Courtney
AU  - Meredith G Dixon
AU  - Louvina van der Laan
AU  - Rada Savic
AU  - Belen Solans
AU  - Kelly Dooley
AU  - Deron Burton
AU  - Shaun Barnabas
AU  - Avy Violari
AU  - Kia Bryant
AU  - Nigel Scott
AU  - Patrick Phillips
AU  - Erin Sizemore
AU  - Wendy Carr
AU  - Susan Purchase
AU  - Elri Nortier
AU  - Joh-Nell van der Westhuizen
AU  - Anne-Marie Demers
AU  - Anneke Hesseling
AU  - Rosanna Boyd
PY  - 2026
JO  - JMIR Research Protocols
DO  - 10.2196/103274
UR  - https://doi.org/10.2196/103274
ER  -

APA

Courtney, I., Dixon, M. G., Laan, L. V. D., Savic, R., Solans, B., Dooley, K., Burton, D., Barnabas, S., Violari, A., Bryant, K., Scott, N., Phillips, P., Sizemore, E., Carr, W., Purchase, S., Nortier, E., Westhuizen, J. V. D., Demers, A., Hesseling, A., & Boyd, R. (2026). Dosing and Safety of Once-Weekly Rifapentine and Isoniazid for 12 Weeks for Tuberculosis Preventive Therapy in Children With and Without HIV: Protocol for a Phase I/II Open-Label, Exposure-Controlled, Dose-Finding, and Safety Study (Tuberculosis Trials Consortium Study 35). JMIR Research Protocols. https://doi.org/10.2196/103274

Source records

crossref · retrieved 2026-11-10T00:42:20.995Z